Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Legionella Testing Market, by Type
1.4.2 Europe Legionella Testing Market, by End-User
1.4.3 Europe Legionella Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Legionella Testing Market, by Type
4.1 Europe Polymerase Chain Reaction (PCR) Market, by Country
4.2 Europe Culture Media Market, by Country
4.3 Europe Urine Antigen Testing (UAT) Market, by Country
4.4 Europe Serology Market, by Country
4.5 Europe Direct Fluorescent Antibody (DFA) Test Market, by Country
Chapter 5. Europe Legionella Testing Market, by End-User
5.1 Europe Clinical Laboratories Market, by Country
5.2 Europe Hospitals & Clinics Market, by Country
5.3 Europe Others Market, by Country
Chapter 6. Europe Legionella Testing Market, by Country
6.1 Germany Legionella Testing Market
6.1.1 Germany Legionella Testing Market, by Type
6.1.2 Germany Legionella Testing Market, by End-User
6.2 UK Legionella Testing Market
6.2.1 UK Legionella Testing Market, by Type
6.2.2 UK Legionella Testing Market, by End-User
6.3 France Legionella Testing Market
6.3.1 France Legionella Testing Market, by Type
6.3.2 France Legionella Testing Market, by End-User
6.4 Russia Legionella Testing Market
6.4.1 Russia Legionella Testing Market, by Type
6.4.2 Russia Legionella Testing Market, by End-User
6.5 Spain Legionella Testing Market
6.5.1 Spain Legionella Testing Market, by Type
6.5.2 Spain Legionella Testing Market, by End-User
6.6 Italy Legionella Testing Market
6.6.1 Italy Legionella Testing Market, by Type
6.6.2 Italy Legionella Testing Market, by End-User
6.7 Rest of Europe Legionella Testing Market
6.7.1 Rest of Europe Legionella Testing Market, by Type
6.7.2 Rest of Europe Legionella Testing Market, by End-User
Chapter 7. Company Profiles
7.1 QuidelOrtho Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Merck KGaA
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Thermo Fisher Scientific, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Becton, Dickinson, and Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 BioMerieux S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 IDEXX Laboratories, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Eurofins Scientific SE
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 SWOT Analysis
7.10. Qiagen N.V.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
Unique Offerings 